ARCHIVES

Health Canada Suspends Avastin Approval; CMS Has Taken No Action After FDA Decision

This article is from The Cancer Letter archive.

Vol. 37 No. 44 | December 2, 2011

Download PDF Visit The Full Archive

Related Articles

In Brief: Robert Bast Succeeds Singleton As Director Of Duke Cancer Center; Robert Bell Deputy

August 14, 1987

DeVita: No Decision Yet On FCRF Award

July 17, 1987

NCI to Recompete contracts for Frederick

December 4, 1992

Abraxane Improves Progression-Free Survival Compared to Decarbazine In Stage IV Disease

November 30, 2012

U.S. Breast Cancer Death Rate Declines.

September 28, 2007

Underpowered Study Of Evacet Dashes Approval Hopes

September 24, 1999